NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled
NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT00499733 2019-01-18Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase EARLY_PHASE1 Terminated19 enrolled